Philadelphia, Pennsylvania, United States Robin Hood Ventures is the famous VC, which was founded in 1999. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Philadelphia.
The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline OneTwoSee, Inpensa, ChargeItSpot For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Financial Services, Enterprise Software.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Robin Hood Ventures, startups are often financed by BioAdvance, Ben Franklin Technology Partners of Southeastern Pennsylvania, Nextstage Capital. The meaningful sponsors for the fund in investment in the same round are Ben Franklin Technology Partners of Southeastern Pennsylvania, Delaware Crossing Investor Group, Mid Atlantic Angel Fund. In the next rounds fund is usually obtained by BioAdvance, Alumni Ventures Group, SoundBoard Venture Fund.
Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. When the investment is from Robin Hood Ventures the average startup value is 1-5 millions dollars. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. This Robin Hood Ventures works on 19 percentage points less the average amount of lead investments comparing to the other organizations.
We also calculated 21 valuable employees in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 4iP | England, London, United Kingdom |
| Brazos Group | Texas, United States, Waco |
| City of London | England, London, United Kingdom |
| Luying Chuangye Touzi | China, Guangdong, Shenzhen |
| Regent Capital Partners | New York, New York, United States |
| Salt Ventures | - |
| Sawai | Japan, Tokyo |
| tbd ventures | California, Los Angeles, United States |
| U-Tokyo Entrepreneur Supporter's Club Incubation Fund | Japan, Tokyo |
| Zhejiang Donghai Juhe Investment | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vytala | 19 Sep 2024 | Malvern, Pennsylvania, United States | |||
S2N Health | 23 May 2024 | Boston, Massachusetts, United States | |||
Proscia | $9M | 11 Jan 2024 | Philadelphia, Pennsylvania, United States | ||
Epoxy.ai | 31 Jul 2023 | Lancaster, Pennsylvania, United States | |||
Wavely Diagnostics, Inc. | $1M | 12 Jul 2023 | Seattle, Washington, United States | ||
Verdafresh | $2M | 09 Jun 2023 | Wayne, Pennsylvania, United States | ||
Wavely Diagnostics, Inc. | 07 Jun 2023 | Seattle, Washington, United States | |||
ChargeItSpot | 04 May 2023 | Philadelphia, Pennsylvania, United States | |||
Hanimune Therapeutics | 28 Apr 2023 | - |
– Sonnest, Inc. raised more than $4M in an oversubscribed Series A financing.
– The round was led by the SWAN Impact Network, Robin Hood Ventures and the Texas Halo Fund and included a number of doctors, and prominent angel investors.
– The funds will be used to advance Electrast™ into the clinic, confirm the safety profile of the drug and generate proof-of-principle ultrasound images in human patients similar to the videos created to date in pigs and dogs.
– The company is also announcing that it has selected a new CEO, Peter Boyd, who is a serial healthcare entrepreneur who sold his last company to Edwards Lifesciences for $100M upfront and up to $150M in milestone payments.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vytala | 19 Sep 2024 | Malvern, Pennsylvania, United States | |||
S2N Health | 23 May 2024 | Boston, Massachusetts, United States | |||
Proscia | $9M | 11 Jan 2024 | Philadelphia, Pennsylvania, United States | ||
Epoxy.ai | 31 Jul 2023 | Lancaster, Pennsylvania, United States | |||
Wavely Diagnostics, Inc. | $1M | 12 Jul 2023 | Seattle, Washington, United States | ||
Verdafresh | $2M | 09 Jun 2023 | Wayne, Pennsylvania, United States | ||
Wavely Diagnostics, Inc. | 07 Jun 2023 | Seattle, Washington, United States | |||
ChargeItSpot | 04 May 2023 | Philadelphia, Pennsylvania, United States | |||
Hanimune Therapeutics | 28 Apr 2023 | - |
